Yngvar Fløisand (Yngvar Floisand)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

Nature communications

Nature medicine

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hong Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nature medicine 30 (8) (2024)
Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hong Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nature medicine 30 (8) (2024)
Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hong Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nature medicine (2024)
Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hong Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nature medicine 30 (8) (2024)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Yngvar Fløisand, Mats Remberger, Iris Bigalke, Dag Josefsen, Helen Vålerhaugen, Else Marit Inderberg, Richard W Olaussen, Bjorn Tore Gjertsen, Rene Goedkoop, Christiane Geiger, Petra U Prinz, Frauke M Schnorfeil, Kai Pinkernell, Dolores J Schendel, Gunnar Kvalheim
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy. Leukemia (2023)
Camilla Dao Vo, Anders Eivind Myhre, Ingerid Weum Abrahamsen, Mats Remberger, Jonas Mattsson, Yngvar Fløisand, Bjørn Christer Linder Grønvold, Geir Erland Tjønnfjord, Tor Henrik Anderson Tvedt, Tobias Gedde-Dahl
Allogeneic stem cell transplantation in adults 2015-21. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 143 (4) (2023)
Camilla Dao Vo, Anders Eivind Myhre, Ingerid Weum Abrahamsen, Mats Remberger, Jonas Mattsson, Yngvar Fløisand, Bjørn Christer Linder Grønvold, Geir Erland Tjønnfjord, Tor Henrik Anderson Tvedt, Tobias Gedde-Dahl
Allogeneic stem cell transplantation in adults 2015-21. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 143 (4) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagiotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit M Enserink, Nello Blaser, Bjorn Tore Gjertsen
Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nature communications 14 (1) (2023)
Tim Grob, Mathijs Arnoud Sanders, Christian M Vonk, Franҫois G Kavelaars, Melissa Rijken, Diana W Hanekamp, Patrycja L Gradowska, Jacqueline Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy, Markus Gabriel Manz, Gert J Ossenkoppele, Lidwine W Tick, Violaine Havelange, Bob Löwenberg, Mojca Jongen-Lavrencic, Peter J M Valk
Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Alejandro Garcia-Horton, Sunu L Cyriac, Tobias Gedde-Dahl, Yngvar Fløisand, Mats Remberger, Jonas Mattsson, Fotios V Michelis
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. European journal of haematology 109 (6) (2022)
Yngvar Fløisand, Mark A Schroeder, Patrice Chevallier, Dominik Selleslag, Steven Devine, Anne S Renteria, Florent Malard, Ibrahim Yakoub Agha, Chunlin Chen, Andrejus Parfionovas, Syed Quadri, Johan Jansson, Mona Akbari, Yi-Bin Chen
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease. Bone marrow transplantation 56 (10) (2021)
Håvard Anton Kristiansen, Signe Spetalen, Yngvar Fløisand, Dag Heldal
Eltrombopag in Good's Syndrome. Case reports in hematology 2014 (2014)